Genekam making ready
for Nasdaq IPO 2024
The results of the above conference are as follows: 17 meetings were confirmed. 14 meetings with investment banks and investors took place. Now we have to do the follow up these meeting with investment banks and investors to see the final results.
Genekam Biotechnology AG has its own quality management system, which is equal to ISO 13485; therefore we have a number of CE-IVD kits.